Related Experiment Video
Updated: Dec 27, 2025
06:23
Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
9.1K
Coagulation testing and management in liver disease patients
Matthew J Stotts1, Jessica P E Davis, Neeral L Shah
1Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia, USA.
Current Opinion in Gastroenterology
|March 7, 2020
Summary
Coagulation testing in liver disease is complex. Advanced liver disease requires considering global clot formation tests and targeted transfusion strategies beyond traditional coagulation tests for effective patient management.
Area of Science:
- Hepatology
- Hematology
- Clinical Medicine
Background:
- Traditional coagulation tests inadequately assess bleeding risk in liver disease.
- Advanced liver disease alters hemostasis, affecting both procoagulant and anticoagulant factors.
Purpose of the Study:
- Provide clinicians with an overview of coagulation testing in liver disease.
- Discuss procoagulants and their use.
- Offer management strategies for clinical scenarios.
Main Methods:
- Review of current literature on coagulation testing in liver disease.
- Discussion of traditional and global clot formation tests (e.g., viscoelastic testing, thrombin generation).
- Analysis of transfusion strategies and procoagulant use.
Main Results:
- Traditional tests like INR do not fully capture hemostatic changes in cirrhosis.
- Global clot formation tests offer practical insights but lack validated targets.
- Targeted transfusion strategies for platelets and fibrinogen may optimize clot formation.
Conclusions:
- Coagulation management in liver disease is evolving beyond traditional testing.
- Global tests and targeted transfusions are emerging tools for clinicians.
- Further validation of optimal target levels for global tests is needed.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
129
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
129
01:30Venous Thrombosis IV: Nursing Management
154
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
154
01:28Esophageal Varices-II: Clinical Features and Management
310
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
310
01:29Venous Thrombosis III: Interprofessional Care
222
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
222
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
166
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
166
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.5K